To evaluate the efficacy of sacubitril/valsartan versus enalapril on changes in NT-proBNP and the safety and tolerability of in-patient initiation of sacubitril/valsartan compared to enalapril in patients admitted for heart failure.
Principal Investigator: Steven Kindsvater, MD
Locations: Baylor Scott & White The Heart Hospital – Plano and Baylor Scott & White Medical Center McKinney
IRB Number: 017-093
Trial Status: Enrolling
Exclusions: Adults only
Change in Care: Participating will change your care
Alexandria Biberstein, RN469.814.4732Alexandria.Biberstein@BSWHealth.org
A multicenter, randomized, double-blind, double-dummy, parallel group, active-controlled 8-week study to evaluate the effect of sacubitril/valsartan (LCZ696) versus enalapril on changes in NT-proBNP and safety and tolerability of in-hospital initiation of sacubitril/valsartan compared to enalapril in HFrEF patients who have been stabilized following hospitalization for acute decompensated heart failure (ADHF).
Get Detailed Information On Clinicaltrials.gov »
Physicians are members of the medical staff at one of Baylor Health Care System's subsidiary, community or affiliated medical centers and are neither employees nor agents of those medical centers, Baylor Scott & White The Heart Hospital – Plano or Baylor Health Care System.